Form 4: Molina Healthcare Director Stephen Lockhart Receives Equity Grant Under 2025 Incentive Plan

Molina Healthcare, Inc. Director Stephen H. Lockhart acquired 180 shares of common stock on July 1, 2025, as part of the company's 2025 Equity Incentive Plan for director services.

Summary

• Stephen H. Lockhart, a Director of Molina Healthcare, Inc. (MOH), acquired 180 shares of common stock.
• The transaction occurred on July 1, 2025.
• The shares were acquired at a price of $306.29 per share.
• This acquisition is a grant under the Issuer's 2025 Equity Incentive Plan, specifically for services as a Director.
• The annual equity award for each director is set at $220,000, with $55,000 granted quarterly based on the closing stock price.
• Following this transaction, Stephen H. Lockhart beneficially owns 3,140 shares of Molina Healthcare common stock directly.

Sentiment

Score: 6

Explanation: The document reports a routine, pre-planned equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain any negative or significantly positive news regarding company performance or outlook.

Positives

• Director Stephen H. Lockhart received an equity grant, aligning his interests with shareholders.
• The grant is part of a structured 2025 Equity Incentive Plan, indicating a clear compensation strategy for directors.
• The company's common stock closing price on July 1, 2025, was $306.29, which is the basis for the grant valuation.

Future Outlook

The filing indicates a structured equity incentive plan for directors extending into 2025, suggesting ongoing commitment to director compensation through equity.

Industry Context

This is a routine insider transaction filing (Form 4) for a director's equity compensation. It reflects standard corporate governance practices in the healthcare industry where executive and director compensation often includes equity components to align interests with shareholders.

Comparison to Industry Standards

• This type of equity grant to directors is a common practice across publicly traded companies, including those in the healthcare sector, aligning director incentives with long-term shareholder value.
• The specific value of the grant ($220,000 annually, $55,000 quarterly) would typically be benchmarked against peer companies in the healthcare services industry, such as Humana, Centene, or Anthem, to ensure competitive compensation for board members.

Corporate Governance

Stakeholder Impact

• Shareholders: Director's interests are further aligned with shareholders through equity ownership.
• Directors: Receive equity compensation as part of their service.

Next Steps

• Future quarterly equity grants to directors under the 2025 Equity Incentive Plan are expected to continue.

Key Dates

Keywords

Molina Healthcare, MOH, Stephen H. Lockhart, Director, SEC Form 4, Equity Incentive Plan, Stock Grant, Common Stock, Insider Transaction, Corporate Governance